Modeling of the interaction of Na+ and K+ with the binding of dopamine and [3H]WIN 35,428 to the human dopamine transporter

Journal of Neurochemistry

Volumn 72, Issue 3, 1999, Pages 1095-1109

  Li, Li Bin ^a   Reith, Maarten E A ^a,b  

^a ILLINOIS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Dopamine binding; Dopamine transporter; Human; Potassium; Sodium; WIN 35,428 binding

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; POTASSIUM; SODIUM;

ALLOSTERISM; ARTICLE; BINDING AFFINITY; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; PRIORITY JOURNAL;

ALGORITHMS; BINDING, COMPETITIVE; CARRIER PROTEINS; CELL LINE; CHLORIDES; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MODELS, NEUROLOGICAL; NERVE TISSUE PROTEINS; POTASSIUM; PROTEIN BINDING; SODIUM;

EID: 0032974887     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0721095.x     Document Type: Article

References (44)

1. + dependence of the neuronal transport of dopamine. J. Neurochem. 59, 1795-1804.
2. Amejdki-Chab N., Costentin J., and Bonnet J.-J. (1992b) Kinetic analysis of the chloride dependence of the neuronal uptake of dopamine and effect of anions on the ability of substrates to compete with the binding of the dopamine uptake inhibitor GBR 12783. J. Neurochem. 58, 793-800.
3. 3H]GBR 12783 to the dopamine neuronal carrier included in polarized membranes. Eur. J. Pharmacol. 247, 333-340.
4. 3H]GBR 12783 to a site associated with the dopamine uptake carrier. J. Neurochem. 50, 759-765.
5. Buck K. J. and Amara S. G. (1995) Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants. Mol. Pharmacol. 48, 1030-1037.
6. 125I]iodophenyl)tropane-2β-carboxylic acid isopropyl ester to the dopamine transporter. J. Neurochem. 68, 1968-1981.
7. 125I]3β-(iodophenyl)tropan-2β-carboxylic acid isopropyl ester to the dopamine transporter at a physiologically relevant temperature: mutually exclusive binding and different ionic requirement for various uptake blockers and substrates. Synapse 25, 155-162.
8. Edvardsen O. and Dahl S. G. (1994) A putative model of the dopamine transporter. Mol. Brain Res. 27, 265-274.
9. Ehlert F. J. (1988) Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol. Pharmacol. 33, 187-194.
10. 3H]GBR 12935 to rat and bovine striata. Membr. Biochem. 10, 129-144.
11. Eshleman A. J., Henningsen R. A., Neve K. A., and Janowsky A. (1994) Release of dopamine via the human transporter. Mol. Pharmacol. 45, 312-316.
12. Eshleman A. J., Neve R. L., Janowsky A., and Neve K. A. (1995) Characterization of a recombinant human dopamine transporter in multiple cell lines. J. Pharmacol. Exp. Ther. 274, 276-283.
13. Eshleman A. J., Stewart E., Evenson A. K., Mason J. N., Blakely R. D., Janowsky A., and Neve K. A. (1997) Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters. J. Neurochem. 69, 1459-1466.
14. Giros B., el Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., and Caron M. G. (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42, 383-390.
15. Giros B., Wang Y. M., Suter S., McLeskey S. B., Pifl C., and Caron M. G. (1994) Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol Chem. 269, 15985-15988.
16. Gu H. H. and Rudnick G. (1996) A thermodynamic study of the dopamine transporter ion-coupling mechanism. Soc. Neurosci. Abstr. 22, 370.
17. Gu H., Wall S. C., and Rudnick G. (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269, 7124-7130.
18. 3H)dopamine by homogenates of rat corpus striatum: effects of cations. Life Sci. 13, 303-312.
19. 3H]GBR 12783 binding to the dopamine neuronal carrier. Eur. J. Pharmacol. 301, 195-202.
20. 3H]dopamine into synaptosomes from rat striatum. Mol. Pharmacol. 10, 746-758.
21. Humphreys C. J., Wall S. C., and Rudnick G. (1994) Ligand binding to the serotonin transporter: equilibria, kinetics, and ion dependence. Biochemistry 33, 9118-9125.
22. Kitayama S., Shimada S., Xu H., Markham L., Donovan D. M., and Uhl G. R. (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. USA 89, 7782-7785.
23. Mager S., Min C., Henry D. J., Chavkin C., Huffman B. J., Davidson N., and Lester H. A. (1994) Conducting states of a mammalian serotonin transporter. Neuron 12, 845-859.
24. McElvain J. S. and Schenk J. O. (1992) A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine. Biochem. Pharmacol. 43, 2189-2199.
25. Meiergerd S. M., Hooks S. M., and Schenk J. O. (1994) The striatal transporter for dopamine in the rat may be kinetically up-regulated following 3 weeks of withdrawal from cocaine self-administration. J. Neurochem. 63, 1277-1281.
26. 3H]GBR 12,935 binding. Mol. Pharmacol. 45, 125-135.
27. 3H]tropane to the dopamine uptake carrier. J. Neurochem. 61, 167-177.
28. Reith M. E. A., de Costa B., Rice K. C., and Jacobson A. E. (1992) Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935, and dopamine to the dopamine transporter. Eur. J. Pharmacol. 227, 417-425.
29. Reith M. E. A., Xu C., Zhang L., and Coffey L. L. (1996) Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter. Naunyn Schmiedebergs Arch. Pharmacol. 354, 295-304.
30. Rudnick G. (1997) Mechanisms of biogenic amine neurotransmitter transporters, in Neurotransmitter Transporters: Structure, Function, and Regulation (Reith M. E. A., ed), pp. 73-100. Humana Press. Totowa, New Jersey.
31. 3H]methylphenidate binding and synaptosomal dopamine transport. Soc. Neurosci. Abstr. 13, 1111.
32. Sershen H., Reith M. E. A., and Lajtha A. (1982) Comparison of the properties of central and peripheral binding sites for cocaine. Neuropharmacology 21, 469-474.
33. Shank R. P., Schneider C. R., and Tighe J. J. (1987) Ion dependence of neurotransmitter uptake: inhibitory effects of ion substitutes. J. Neurochem. 49, 381-388.
34. Shepherd G. M. (1983) Neurobiology, Oxford University Press, New York.
35. Sonders M. S., Zhu S. J., Zahniser N. R., Kavanaugh M. P., and Amara S. G. (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J. Neurosci. 17, 960-974.
36. Sur C., Betz H., and Schloss P. (1997) A single serine residue controls the cation dependence of substrate transport by the rat serotonin transporter. Proc. Natl. Acad. Sci. USA 94, 7639-7644.
37. Tomlinson G. and Hnatowich M. R. (1988) Apparent competitive inhibition of radioligand binding to receptors: experimental and theoretical considerations in the analysis of equilibrium binding data. J. Recept. Res. 8, 809-830.
38. Ungell A. L., Oberleithner H., and Grafe K. H. (1989) Chloridedependence of the potency of inhibitors of the neuronal miradrenaline carrier in the rat vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 339, 65-70.
39. 125I]iodophenyl)tropane binding. Mol. Pharmacol. 43, 264-270.
40. Wheeler D. D., Edwards A. M., Chapman B, M., and Ondo J. G. (1994) Effects of cocaine on sodium dependent dopamine uptake in rat striatal synaptosomes. Neurochem. Res. 19, 49-56.
41. 3H]WIN 35,428 binding to the human dopamine transporter in a similar fashion. J. Neurochem. 69, 1106-1118.
42. Xu C., Coffey L. L., and Reith M. E. A. (1995) Translocation of dopamine and binding of 2β-carbomethoxy-3β-(4-fluorophenyl)-tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers. Biochem. Pharmacol. 49, 339-350.
43. 3H]WIN 35,428 binding. Naunyn Schmiedebergs Arch. Pharmacol. 355, 64-73.
44. Zimanyi I., Lajtha A., and Reith M. E. A. (1989) Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum. Naunyn Schmiedebergs Arch. Pharmacol. 340, 626-632.